Efficacy and safety of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma (BCC): ERIVANCE BCC study update Sekulic, A., Migden, M. R., Oro, A. E., Lewis, K. D., Hainsworth, J. D., Yoo, S., Dirix, L., Hou, J., Yue, H., Hauschild, A., ERIVANCE BCC Study Investigators AMER SOC CLINICAL ONCOLOGY. 2012

View details for Web of Science ID 000318009800685